跳至主要内容
临床试验/NCT05191056
NCT05191056已完成不适用

Anti-aging and Anti-oxidant Efficacy Evaluation of the MelaGene

TCI Co., Ltd.2 个研究点 分布在 1 个国家目标入组 51 人开始时间: 2021年9月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
TCI Co., Ltd.
入组人数
51
试验地点
2
主要终点
The change of blood lipid (Triglyceride, total cholestrol, HDL-C, LDL-C)

研究概览

简要总结

The primary purpose of the present study is to evaluate the effects of MelaGene on anti-aging and anti-oxidant.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
30 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 30 to 65-year-old;
  • Must read and sign the informed consent form before the experiment;
  • People who are willing to cooperate with contraception during the trial period;
  • Do not change lifestyle and eating habits arbitrarily during the trial period;
  • Do not take supplementary foods and health supplements with the same efficacy two weeks before and during the test;
  • If any adverse reaction occurs during the experiment, subjects should be notified the researcher immediately.

排除标准

  • Subject who is not willing to participate in this study;
  • Vegetarians;
  • People with a history of organ transplantation, epilepsy or convulsions, liver and kidney disease, malignant tumors, endocrine diseases, mental illness, alcohol or drug abuse, and other major organic diseases (according to medical history);
  • Participate in other clinical trials related to antioxidants and anti-aging four weeks before and during the test;
  • People with a history of dyspepsia would affect the absorption of the test product;
  • Allergic to the components of the test product;
  • Pregnant or breast-feeding women;
  • Take anti-oxidant supplements;
  • Undergoing hormone replacement therapy.

结局指标

主要结局

The change of blood lipid (Triglyceride, total cholestrol, HDL-C, LDL-C)

时间窗: Days 1, 28, and 56

Venous blood is sampled to measure concentrations of blood lipid (Triglyceride, total cholestrol, HDL-C, LDL-C)

The change of ALT and AST

时间窗: Days 1, 28, and 56

Venous blood is sampled to measure concentrations of ALT and AST

The change of MDA

时间窗: Days 1, 28, and 56

Venous blood is sampled to measure concentrations of MDA

The change of blood antioxidants(f-Thiols, t-GSH, GST-RBC, SOD, Total Anit-oxidative Capicity)

时间窗: Days 1, 28, and 56

Venous blood is sampled to measure concentrations of blood antioxidants(f-Thiols, t-GSH, GST-RBC, SOD, Total Anit-oxidative Capicity)

The change of anti-aging gene expression

时间窗: Days 1, 28, and 56

Venous blood is sampled to measure expression of anti-aging gene

The change of cardiovascular endurance

时间窗: Days 1, 28, and 56

Step test is designed to assess cardiovascular endurance

次要结局

  • The change of fatigue condition(Days 1, 28, and 56)
  • The change of continuous attention test(Days 1, 28, and 56)

研究者

发起方
TCI Co., Ltd.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验